Clinical characteristics and follow‑up of Saudi patients with adrenal incidentalomas: single‑center experience
BMC Endocrine Disorders · 14.08.2026 · 26 (1)
DOI: 10.1186/s12902-026-02497-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift BMC Endocrine Disorders, online erschienen am 14.08.2026. Verfasst von Bader Alharbi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia. baalharbi@kfmc.med.sa. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adrenal incidentalomas (AIs) are increasingly detected owing to the widespread use of cross-sectional imaging. However, real-world adherence to guideline-recommended evaluation remains variable. This study aimed to determine the prevalence, characteristics, and workup patterns of AIs at a tertiary care center in Saudi Arabia.
Methods
We conducted a retrospective observational study of 250 patients diagnosed with adrenal incidentalomas at King Fahad Medical City between March 2021 and August 2023. Demographic, radiologic, and hormonal data were collected and analyzed.
Results
The mean age was 59.9 ± 13.5 years, with a nearly equal sex distribution. Most lesions were small (57.2% were 1–2 cm) and unilateral (79.6%). Only 20% ( n = 50) of patients underwent a complete hormonal evaluation. Among these 50 patients, 12.0% ( n = 6) had a functioning tumor and 88.0% ( n = 44) were non-functioning; expresedd relative to the entire cohort, functioning tumors corresponded to only 2.4% ( n = 6), reflecting the impact of the 80% non-evaluation rate on the apparent overall prevelance. Adenomas were the most frequent diagnosis (52.8%), while malignancy was suspected or confirmed in 14.4%. Dedicated adrenal imaging was underutilized, with 94.8% lacking contrast washout studies. Multivariate analysis identified younger age (≤ 60 years), specialty referral, and absence of active malignancy as independent predictors of hormonal evaluation.
Conclusion
This study highlights a substantial gap between clinical guidelines and real-world practice in the evaluation of AIs. Standardized institutional protocols are urgently needed to prevent underdiagnosis of hormonally active or malignant lesions. Clinical trial number Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Department, Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia. baalharbi@kfmc.med.sa.
- Obesity, Endocrine, and Metabolism Center, Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia. baalharbi@kfmc.med.sa.
- Internal Medicine Department, Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia.
- Obesity, Endocrine, and Metabolism Center, Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Zitieren
APA
Alharbi, B., Almohaimeed, M., Aljohani, E., & Almalki, M. (2026). Clinical characteristics and follow‑up of Saudi patients with adrenal incidentalomas: single‑center experience. BMC Endocrine Disorders, 26(1). https://doi.org/10.1186/s12902-026-02497-3
Vancouver
Alharbi B, Almohaimeed M, Aljohani E, Almalki M. Clinical characteristics and follow‑up of Saudi patients with adrenal incidentalomas: single‑center experience. BMC Endocrine Disorders. 2026;26(1). doi:10.1186/s12902-026-02497-3
BibTeX
@article{Alharbi2026,
author = {Alharbi, Bader and Almohaimeed, Mohannad and Aljohani, Eid and Almalki, Mussa},
title = {Clinical characteristics and follow‑up of Saudi patients with adrenal incidentalomas: single‑center experience},
journal = {BMC Endocrine Disorders},
year = {2026},
volume = {26},
number = {1},
doi = {10.1186/s12902-026-02497-3}
}
EUVIMED